Cytometry Part B Clinical Cytometry · 2019 · 15 citations · 9 references
MedicineHematologyPathologyHematologic OncologyHematopathologyHistopathologyBone Marrow EvaluationBone Marrow PathologyHematologic MalignanciesHematologic PathologyLymphoid NeoplasmsBone Marrow AssessmentBone Marrow Involvement AssessmentBone Marrow StagingFlow Cytometric Marrow AnalysisFlow Cytometry ImmunophenotypingInfiltrationLymphoma Bone Marrow InvolvementLymphoma Staging
BACKGROUND: The significance of discrepant findings between histology (BMB) and flow cytometry (FC) in bone marrow (BM) examination at diffuse large B-cell lymphoma (DLBCL) diagnosis is uncertain. METHODS: We performed a 5-year retrospective single-center study of patients diagnosed by DLBCL not otherwise specified (n = 82), divided into three groups according to BM infiltration at diagnosis: BMB-/FC- (75.6%), BMB+/FC+ (13.4%), and BMB-/FC+ (11%). RESULTS: Median infiltration by FC analysis of the BMB-/FC+ group was 0.8% and if we considered BM infiltration as positive in all cases, 4/9 would be upstaged. Median follow was 33 months. Event-free survival (EFS) after 18 months was 82, 23, and 27% for BMB-/FC-, BMB-/FC+, and BMB+/FC+, respectively (p < .001). After 18 months of observation, OS was 87, 46, and 55% for BMB-/FC-, BMB-/FC+, and BMB+/FC+, respectively (p = .001). In multivariate analysis (BM infiltration vs. cell-of-origin according to Hans algorithm and standard IPI), BM infiltration was independently associated with EFS (HR: 1.94, 95% CI: 1.3-2.9) and overall survival (HR: 1.69, 95% CI: 1.1-2.7). CONCLUSION: In summary, minimal BM infiltration, detected by FC but not by BMB, has same prognostic implications than overt BM infiltration and should be considered as extranodal involvement regardless the infiltration quantity.
9
Revised Response Criteria for Malignant Lymphoma
Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text
Shaoying Li, Ken H. Young, L. Jeffrey Medeiros · Pathology · 2017 · 630 citations
Medicine, Dermatology, Oncology +11
Clinical utility of bone marrow flow cytometry in B‐cell non‐Hodgkin lymphomas (B‐NHL)
G Perea, Albert Altés, Mar Bellido et al. · Histopathology · 2004 · 49 citations · Full text
Medicine, Hematology, Pathology +17
Stefania Pittaluga, Anne Tierens, Ygierne L. Dodoo et al. · American Journal of Clinical Pathology · 1999 · 49 citations · Full text
Medicine, Hematology, Pathology +17